Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Epigenetic and Post-Translational Modifications in Ferroptosis Regulation and Hepatocellular Carcinoma: New Frontiers in Therapeutic Targeting Publisher Pubmed



Bolandi S1 ; Dodge S2 ; Zahed Z3 ; Soleimani A4 ; Monirvaghefi K5 ; Ghodsifar M6 ; Ghasemi M7 ; Aghajamal Avval N8 ; Zadeh SSM9 ; Fazayel SMA10 ; Morovatshoar R11 ; Barfi V12 ; Behfar Q13 ; Dehghani S14
Authors

Source: Pathology, research and practice Published:2025


Abstract

Hepatocellular carcinoma (HCC), the predominant kind of liver cancer, continues to be a significant contributor to cancer-related deaths globally, influenced by intricate molecular processes and strong resistance to existing chemotherapy. Iron-dependent lipid peroxidation induces ferroptosis, a controlled form of cell death that plays a crucial role in inhibiting tumor growth and treatment resistance in HCC. Recent research has shown that epigenetic modifications, such as DNA methylation, histone modifications, regulation by non-coding RNAs (ncRNAs), and post-translational modification (PTM) like ubiquitination, phosphorylation, acetylation, and methylation, play a crucial role in fine-tuning ferroptosis. These alterations alter the structure of chromatin, gene expression, and protein function, thereby affecting cancer cells' fate. This review emphasizes the complex functions of epigenetic and post-translational alterations in controlling ferroptosis, providing valuable insights into their potential as therapeutic targets in HCC. The unraveling of these pathways offers a significant opportunity for novel therapies targeted at surmounting drug resistance and enhancing patient outcomes in liver cancer. Copyright © 2025. Published by Elsevier GmbH.
Related Docs
View other Related Docs
1. Targeting Ferroptosis As a Cell Death Pathway in Melanoma: From Molecular Mechanisms to Skin Cancer Treatment, International Immunopharmacology (2023)
2. Ferroptosis As a Therapeutic Target in Glioblastoma: Mechanisms and Emerging Strategies, Molecular Therapy Nucleic Acids (2025)
3. Emerging Role of Mirnas in the Regulation of Ferroptosis, Frontiers in Molecular Biosciences (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Zahra Pourpak (1)
Other Related Docs
4. Biological and Immunological Aspects of Iron Deficiency Anemia in Cancer Development: A Narrative Review, Nutrition and Cancer (2018)
5. Iron Oxide Nanoparticles Conjugated to Thiosemicarbazone Reduce the Survival of Cancer Cells by Increasing the Gene Expression of Microrna Let-7C in Lung Cancer A549 Cells, Archives of Iranian Medicine (2022)
6. Non-Coding Rnas in the Regulation of Ferroptosis in Cancer, (2025)
7. Targeting Ferroptosis in Gastrointestinal Tumors: Interplay of Iron-Dependent Cell Death and Autophagy, Molecular and Cellular Probes (2025)
8. Ferroptosis As a Promising Targeted Therapy for Triple Negative Breast Cancer, Breast Cancer Research and Treatment (2024)
9. Natural Products and the Balancing Act of Autophagy-Dependent/Independent Ferroptosis in Cancer Therapy, Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
10. Targeting Non-Apoptotic Cell Death in Cancer Treatment by Nanomaterials: Recent Advances and Future Outlook, Nanomedicine: Nanotechnology# Biology# and Medicine (2020)
11. Interplay Between Gut Microbiota and the Master Iron Regulator, Hepcidin, in the Pathogenesis of Liver Fibrosis, Pathogens and Disease (2024)
12. Biological Landscape and Nanostructural View in Development and Reversal of Oxaliplatin Resistance in Colorectal Cancer, Translational Oncology (2024)
13. Microrna-Based Linkage Between Aging and Cancer: From Epigenetics View Point, Cell Journal (2016)
14. Natural Products Targeting Ferroptosis in Type 2 Diabetes Mellitus and Its Complications, Phytotherapy Research (2025)
15. The Role of Non-Coding Rnas in the Regulation of Cell Death Pathways in Melanoma, Discover Oncology (2025)
16. Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate Through Non-Apoptotic Cell Death?, Biomedicines (2023)
17. Advanced Therapeutic Modalities in Hepatocellular Carcinoma: Novel Insights, Journal of Cellular and Molecular Medicine (2021)
18. Unveiling the Intersection: Ferroptosis in Influenza Virus Infection, Virology Journal (2024)
19. Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review, Cancers (2023)
20. Non-Coding Rnas in Leukemia Drug Resistance: New Perspectives on Molecular Mechanisms and Signaling Pathways, Annals of Hematology (2024)